Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  DaVita Inc.    DVA

DAVITA INC.

(DVA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/29/2020 07/30/2020 07/31/2020 08/03/2020 08/04/2020 Date
91.3(c) 91.12(c) 87.39(c) 87.21(c) 83.57(c) Last
896 714 1 369 260 1 830 827 909 526 1 212 062 Volume
+3.76% -0.20% -4.09% -0.21% -4.17% Change
More quotes
Financials (USD)
Sales 2020 11 607 M - -
Net income 2020 786 M - -
Net Debt 2020 6 599 M - -
P/E ratio 2020 13,2x
Yield 2020 -
Sales 2021 11 862 M - -
Net income 2021 815 M - -
Net Debt 2021 6 579 M - -
P/E ratio 2021 12,1x
Yield 2021 -
Capitalization 10 196 M 10 196 M -
EV / Sales 2020 1,45x
EV / Sales 2021 1,41x
Nbr of Employees 65 000
Free-Float 91,1%
More Financials
Company
DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows: - supply of dialysis services (95.7%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2019, services are insured through 2,753 dialysis centers serving nearly 206,900 patients in the United States, and through 259 dialysis centers serving nearly 28,700... 
More about the company
Surperformance© ratings of DaVita Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DAVITA INC.
07/30DAVITA : Management's Discussion and Analysis of Financial Condition and Results..
AQ
07/30DAVITA INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
07/15DAVITA INC. : Schedules 2nd Quarter 2020 Investor Conference Call
PR
06/17GILEAD SCIENCES : Javier Rodriguez Joins Gilead Sciences Board of Directors
AQ
06/17DAVITA KIDNEY CARE : Appoints Chief Nursing Officer
PR
06/17DAVITA INC. : Change in Directors or Principal Officers (form 8-K)
AQ
06/09DAVITA INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
05/28NEPHROLOGY PRACTICE SOLUTIONS : Names New Chief Medical Officer
PR
05/26DAVITA INC. : Announces Pricing of $1.75 Billion Senior Notes Offering
PR
05/26DAVITA INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/26DAVITA INC. : Announces Offering of $1.75 Billion Senior Notes
PR
05/20South Africa's Tiger Brands books $30 mln impairment on export businesses
RE
05/07DAVITA : Continues to Support Teammates during COVID-19 Crisis
PR
05/05DAVITA : Management's Discussion and Analysis of Financial Condition and Results..
AQ
05/05Videogame Makers Benefit as Consumers Stay Home -- Earnings at a Glance
DJ
More news
News in other languages on DAVITA INC.
07/30DAVITA : Management's Discussion and Analysis of Financial Condition and Results..
07/30DAVITA INC. : Results of Operations and Financial Condition, Financial Statement..
07/15DAVITA INC. : Schedules 2nd Quarter 2020 Investor Conference Call
06/17GILEAD SCIENCES : Javier Rodriguez Joins Gilead Sciences Board of Directors
06/17DAVITA KIDNEY CARE : Appoints Chief Nursing Officer
More news
Chart DAVITA INC.
Duration : Period :
DaVita Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DAVITA INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 94,38 $
Last Close Price 83,57 $
Spread / Highest target 25,6%
Spread / Average Target 12,9%
Spread / Lowest Target -5,47%
EPS Revisions
Managers
NameTitle
Javier J. Rodriguez Chief Executive Officer & Director
Pamela M. Arway Chairman
Joel Ackerman Chief Financial Officer
Jeff Giullian Chief Medical Officer
John M. Nehra Independent Non-Executive Director
Sector and Competitors